This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (9)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Neurology  • Headache  • Migraine  • Quality of Care  • Evidence-Based Medicine  • Alert me on articles by topic  Social Bookmarking   What's this?

David B. Matchar, MD; Douglas C. McCrory, MD, MHSc; Rebecca N. Gray, DPhil

JAMA. 2000;284:2640-2641.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Migraine has long been recognized as a painful and debilitating disorder that profoundly affects the lives of individuals and their families. Population studies conducted over the past decade paint a startling picture of migraine as a major public health problem, suggesting that nearly 1 in 5 women and 1 in 20 men have disabling migraine.^1-2 While precise estimates vary, migraine is clearly responsible for millions of bedridden and reduced-activity days per year and billions of dollars in medical costs and lost productivity.^2-4 Yet most people with migraine are never diagnosed by a physician or treated with prescription medication,^{1, 5-6} and those who do receive care are frequently dissatisfied with the results.⁷

In this context, in 1994, the Agency for Health Care Policy and Research (now the Agency for Healthcare Research and Quality [AHRQ]) initiated a project to evaluate . . . [Full Text of this Article]

Author Affiliations: Center for Clinical Health Policy Research, Duke University (Drs Matchar, McCrory, and Gray); Department of Medicine (General Internal Medicine), Duke University Medical Center (Drs Matchar and McCrory); and Department of Veterans Affairs Medical Center (Drs Matchar and McCrory), Durham, NC.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pharmacologic Management of Acute Attacks of Migraine and Prevention of Migraine Headache
Snow et al.
ANN INTERN MED 2002;137:840-849.
ABSTRACT | FULL TEXT  

Prevalence and clinical characteristics of migraine in France
Henry et al.
Neurology 2002;59:232-237.
ABSTRACT | FULL TEXT  

Efficacy of oral ketoprofen in acute migraine: A double-blind randomized clinical trial
Dib et al.
Neurology 2002;58:1660-1665.
ABSTRACT | FULL TEXT  

Aspirin Plus Metoclopramide vs. Zolmitriptan for Migraine
JWatch General 2001;2001:3-3.
FULL TEXT